Exact Sciences
EXACT SCIENCES CORP
Key figures
Period Jan 2025 to Dec 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$3.2B
Operating marginCalculated
-6.4%
Net assets to total assetsCalculated
41.0%
Company profile
Tables scroll sideways
Disclosed data
Profitability
★☆☆☆☆position among all companies
-6.4%
Growth (revenue, 4-year average)
★★★★★position among all companies
16.4%
Capital efficiency
★☆☆☆☆position among all companies
-8.7%
Revenue and profit
Performance, financial position and capital allocation
Exact Sciences
Recent performance trends
Exact Sciences
Cash flow trends
Consolidated indicators (9 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$1.8 billion | US$2.1 billion | US$2.5 billion | US$2.8 billion | US$3.2 billion |
| Operating income | US$-0.9 billion | US$-0.6 billion | US$-0.2 billion | US$-1.0 billion | US$-0.2 billion |
| Net income | US$-0.6 billion | US$-0.6 billion | US$-0.2 billion | US$-1.0 billion | US$-0.2 billion |
| Total assets | US$6.7 billion | US$6.2 billion | US$6.5 billion | US$5.9 billion | US$5.9 billion |
| Shareholders' equity | US$3.4 billion | US$3.0 billion | US$3.1 billion | US$2.4 billion | US$2.4 billion |
| Net cash provided by (used in) operating activities | US$-0.1 billion | US$-0.2 billion | US$0.2 billion | US$0.2 billion | US$0.5 billion |
| Net cash provided by (used in) investing activities | US$-1.1 billion | US$74.07 million | US$49.68 million | US$-0.4 billion | US$0.2 billion |
| Net cash provided by (used in) financing activities | US$8.47 million | US$76.48 million | US$0.2 billion | US$0.2 billion | US$-0.3 billion |
| Cash and cash equivalents | US$0.3 billion | US$0.2 billion | US$0.6 billion | US$0.6 billion | US$1.0 billion |
Revenue scale in the same industry
Exact Sciences
Health services: 20 companies · revenue · largest first・FY Dec 2025・Consolidated・Disclosed
- 1 HCA Healthcare US$75.6B
- 2 Tenet Healthcare US$21.3B
- 3 Universal Health Services US$17.4B
- … 12 companies
- 16 Acadia Healthcare Company US$3.3B
- 17 Surgery Partners US$3.3B
- 18 Exact SciencesThis company US$3.2B
- 19 AdaptHealth US$3.2B
- 20 Brookdale Senior Living US$3.2B
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$0.1 billion | Consolidated | Disclosed |
| Cash and cash equivalents | US$1.0 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-0.3 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$0.2 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$0.5 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$0.1 billion | Consolidated | Disclosed |
| Net assets | US$2.4 billion | Consolidated | Disclosed |
| Net sales | US$3.2 billion | Consolidated | Disclosed |
| Operating income | US$-0.2 billion | Consolidated | Disclosed |
| Net income | US$-0.2 billion | Consolidated | Disclosed |
| Total assets | US$5.9 billion | Consolidated | Disclosed |
| Operating margin | -6.4% | Consolidated | Calculated |
| Net assets to total assets | 41.0% | Consolidated | Calculated |
| Net margin | -6.4% | Consolidated | Calculated |
| Return on equity | -8.7% | Consolidated | Calculated |